1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow HER2-positive Circulating Tumor Cells: new trials by email Literature Review of HER2-positive Circulating Tumor Cells trials Research Report on HER2-positive Circulating Tumor Cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs standard chemo- or endocrine therapy, standard chemo- or endocrine therapy + Lapatinib - HER2-negative Metastatic Breast Cancer, HER2-positive Circulating Tumor Cells | Phase 3 | Completed | Prof. Wolfgang Janni | 105 | 2012-02-01 | 2024-06-04 |
Breast Neoplasms (1) · Neoplastic Cells, Circulating (1)
Breast Diseases (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Lapatinib (1)
Germany (1)
Tanja Fehm, MD, PhD (1) · Wolfgang Janni, MD, PhD (1)